Incidence of atrial fibrillation in patients with Chronic Lymphocytic Leukemia on background therapy of antocoagulants recieving treatment with Ibrutinib
Latest Information Update: 30 Aug 2019
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 22 Jul 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association